Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

If, after reading 111,398 posts and all

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
apostrophe Member Profile
 
Followed By 19
Posts 1,084
Boards Moderated 0
Alias Born 10/17/06
160x600 placeholder
Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/29/2021 7:00:00 AM
Anavex Life provides key updates on clinical trials in rare genetic neurological disorders Seeking Alpha - 11/24/2021 9:40:36 AM
Anavex Life Sciences EPS misses by $0.39 Seeking Alpha - 11/24/2021 7:07:01 AM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results GlobeNewswire Inc. - 11/24/2021 7:00:00 AM
Notable earnings after Wednesday's close Seeking Alpha - 11/23/2021 5:35:23 PM
Anavex Life Sciences FY 2021 Earnings Preview Seeking Alpha - 11/23/2021 1:20:23 PM
Notable earnings before Wednesday's open Seeking Alpha - 11/23/2021 10:42:34 AM
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021 GlobeNewswire Inc. - 11/17/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference GlobeNewswire Inc. - 10/15/2021 7:00:00 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 10/13/2021 7:00:00 AM
Cassava down after phase 3 simufilam announcement; other Alzheimer's names follow Seeking Alpha - 10/6/2021 12:51:22 PM
CEO Presenting on the Emerging Growth Conference on September 29  Register Now InvestorsHub NewsWire - 9/28/2021 8:00:00 AM
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access 2021 GlobeNewswire Inc. - 9/27/2021 9:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 8:11:01 AM
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market® GlobeNewswire Inc. - 9/27/2021 7:00:00 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 9/24/2021 5:05:26 PM
Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference Today!  Register Now InvestorsHub NewsWire - 9/15/2021 7:00:00 AM
Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference Today.  Register Now InvestorsHub NewsWire - 9/1/2021 7:00:00 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Autism) GlobeNewswire Inc. - 8/26/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2021 5:13:54 PM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results GlobeNewswire Inc. - 8/12/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021 GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
apostrophe   Sunday, 07/16/17 06:35:34 PM
Re: F1ash post# 111409
Post # of 338000 
If, after reading 111,398 posts and all the outside bio-science information available you still feel "leery about investing", well, I would say, don't. I believe people who have a portion of their portfolio as a passive investment in Anaves, made their decision a long time ago and don't particularly care whether you invest here or not. Don't feel obligated to follow the crowd.

Why is it so hard to decide? For example, I looked at a competitor with a sample group of three. Well. they started with four. The fourth was ostensibly starting to show signs of improvement right before they died.

Another patient was reported to sit up suddenly like Lazarus and try to vocalize. The spin was that this was an improvement. Well, the compound had been previously shown to produce severe abdominal pains (in mice), so it seems more likely the behavior was due to that and an attempt to scream in pain.

Supposedly, another patient was now "playing pool". Well, how was their game? Were they actually playing before? Or , well, it's pretty easy to prop somebody up with a pool cue in hand and knock a few balls around.

It wasn't necessary to go much further. I not only felt leery, downright quesy at the spin factor at work here. Forget buying into that. though it meant "reading between the lines" a bit. Right?

Now we have, what, 25 or 30 sample group so far with Anavex. Kind of small but enough to get a decent indication. Reading between the lines, very positive indications. many very unambigious clinically tested and clinically credible reports of effectiveness.

A few dropouts. OK. Anything serious? No. These people are old, pushing 80, probably not all with a patient or sunny personality to begin with, one has to expect some to decide to quit. It may be a mistake but it's theirs to make.

I could well imagine some geezer saying" I'm tired of all this silly testing. I feel better. I'm going home!"

One of the reasons I rarely drink anymore compared to when I was young is that I no longer care for the accompanying dizziness and headache. So, same thing. Was the treatment making them deathly ill? No.

The only one that was what, level 2 had dementia. A neighbor's mother had dementia. He had to leave her alone for a couple hours and returned to find that she had built a bonfire on the front lawn. Said she was cold. It was July. The point is that people with dementia don't always exhibit good judgement. Still, they're not guinea pigs (or lab-rats whatever). They can quit whenever they want for any reason. We do know for a fact that no one dropped out for serious adverse events which would have been mandatory to report.

I'm simply sharing some insights on the decision process.

Speaking of graphics, perhaps you'll find the following as useful in that regard as I have. :)

https://investorshub.advfn.com/uimage/uploads/2017/7/16/dufakstock_decision.JPG

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences